Reduction in Total Cardiovascular Events With the PCSK9 Inhibitor Evolocumab in Patients With Cardiovascular Disease in the FOURIER Trial

被引：0
|
作者：
Murphy, Sabina A.
Pedersen, Terje R.
Gaciong, Zbigniew A.
Ceska, Richard
Ezhov, Marat V.
Connolly, Derek
Kraydashenko, Oleg
Jukema, J. Wouter
Toth, Kalman
Tikkanen, Matti J.
Im, Kyungah
Wiviott, Stephen D.
Kurtz, Christopher
Honarpour, Narimon
Giugliano, Robert P.
Keech, Anthony C.
Sever, Peter S.
Sabatine, Marc S.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
LDLPCSK9;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15100
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
    Murphy, Sabina A.
    Pedersen, Terje R.
    Gaciong, Zbigniew A.
    Ceska, Richard
    Ezhov, Maiat, V
    Connolly, Derek L.
    Jukema, J. Wouter
    Toth, Kalman
    Tikkanen, Matti J.
    Im, Kyungah
    Wiviott, Stephen D.
    Kurtz, Christopher E.
    Honarpour, Narimon
    Giugliano, Robert R.
    Keech, Anthony C.
    Sever, Peter S.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2019, 4 (07) : 613 - 619
  • [2] REDUCTION IN TOTAL CARDIOVASCULAR EVENTS WITH THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE COMBINED FOURIER AND FOURIER OPEN-LABEL EXTENSION (OLE) STUDIES
    Murphy, Sabina
    O'Donoghue, Michelle L.
    Wiviott, Stephen
    Atar, Dan
    Keech, Anthony C.
    Kuder, Julia
    Im, KyungAh
    Flores-Arredondo, Jose
    Lopez, J. Antonio G.
    Elliott, Mary
    Wang, Bei
    Monsalvo, Maria Laura
    Abbasi, Siddique A.
    Giugliano, Robert P.
    Sabatine, Marc Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1121 - 1121
  • [3] PCSK9 Inhibitors and Cardiovascular Events
    Goemann, Iuri M.
    Londero, Thiza M.
    Dora, Jose M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 773 - 774
  • [4] PCSK9 Inhibitors and Cardiovascular Events Reply
    Sabatine, Marc S.
    Wasserman, Scott M.
    Stein, Evan A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 774 - 775
  • [5] PCSK9 Inhibition to Reduce Cardiovascular Events
    Dullaart, Robin P. F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1790 - 1791
  • [6] Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease
    Smith, Alex
    Johnson, Drew
    Banks, Joshua
    Keith, Scott W.
    Karalis, Dean G.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [7] The Effect of the PCSK9 Inhibitor Evolocumab on Aldosterone Secretion among High Cardiovascular Risk Patients: A Pilot Study
    Izkhakov, Elena
    Shacham, Yacov
    Serebro, Merav
    Yaish, Iris
    Marcus, Yonit
    Shefer, Gabi
    Tordjman, Karen
    Greenman, Yona
    Stern, Naftali
    Ziv-Baran, Tomer
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [8] Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
    Sabatine, Marc S.
    Leiter, Lawrence A.
    Wiviott, Stephen D.
    Giugliano, Robert P.
    Deedwania, Prakash
    De Ferrari, Gaetano M.
    Murphy, Sabina A.
    Kuder, Julia F.
    Gouni-Berthold, Ioanna
    Lewis, Basil S.
    Handelsman, Yehuda
    Pineda, Armando Lira
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12): : 941 - 950
  • [9] PCSK9 inhibition and clinical cardiovascular outcomes in patients with atherosclerotic cardiovascular disease
    Landmesser, Ulf
    CARDIOVASCULAR RESEARCH, 2017, 113 (08) : E24 - E25
  • [10] Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial
    O'Donoghue, Michelle L.
    Fazio, Sergio
    Giugliano, Robert P.
    Stroes, Erik S. G.
    Kanevsky, Estella
    Gouni-Berthold, Ioanna
    Im, KyungAh
    Pineda, Armando Lira
    Wasserman, Scott M.
    Ceska, Richard
    Ezhov, Marat V.
    Jukema, J. Wouter
    Jensen, Henrik K.
    Tokgozoglu, S. Lale
    Mach, Francois
    Huber, Kurt
    Sever, Peter S.
    Keech, Anthony C.
    Pedersen, Terje R.
    Sabatine, Marc S.
    CIRCULATION, 2019, 139 (12) : 1483 - 1492
12345